AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Denoci-OP Injection

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Denosumab (60mg)

Overview Denoci-OP Injection

Osteoporosis treatment in postmenopausal women and fracture-risk men is facilitated by Denoci-OP Injection. This medication strengthens bones, thereby lowering fracture probability. Administration must be performed by a healthcare provider; self-injection is prohibited. For optimal efficacy, adhere to the prescribed daily schedule and complete the full course of treatment, regardless of perceived improvement. Supplementing with adequate calcium and vitamin D enhances therapeutic response. Common side effects may include headache, limb pain, musculoskeletal discomfort, neuropathy, constipation, and skin rashes. Persistent or worsening side effects warrant immediate medical consultation; management strategies may be available. Prior to commencing Denoci-OP Injection, disclose all other medications to your physician to ensure safe usage. Pregnant or breastfeeding individuals should consult their doctor before initiating treatment.

Primary Ingredients of Denoci-OP Injection

No information provided. Please provide the text you wish me to rephrase.

Uses of Denoci-OP Injection

Brittle bone disease

Major Benefits of Denoci-OP Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Denoci-OP Injection:

  • Musculoskeletal (bone, muscle or joint) pain
  • Pain in extremities
  • Nerve pain
  • Constipation
  • Rash
  • Headache

How to use Denoci-OP Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Denoci-OP Injection works:

Denoci-OP Injection, a monoclonal antibody therapy, targets a protein responsible for bone degradation, resulting in enhanced bone strength and a reduced fracture risk.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when combining Denoci-OP Injection and alcohol. Physician consultation is recommended.

PregnancyPregnancyUNSAFE

Administering Denoci-OP Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician; research involving pregnant women and animals has revealed considerable adverse effects on fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Denoci-OP Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Denoci-OP Injection.

KidneyKidneyCAUTION

Exercise caution when administering Denoci-OP Injection to individuals with advanced renal impairment. Dosage modification of Denoci-OP Injection might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Administering Denoci-OP Injection to individuals with significant hepatic impairment requires careful consideration and potential dose modification. Physician consultation is advised.

What if you forget to take Denoci-OP Injection :

Omit a Denoci-OP Injection dose? Seek medical advice immediately.

Facts to Know About Denoci-OP Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Pain Relievers

FAQs on Denoci-OP Injection

Treatment duration for osteoporosis with Denoci-OP Injection isn't fixed. Regular monitoring, particularly after five years, assesses patient response and tolerability, guiding continued use.
Hair loss is a possible side effect of Denoci-OP Injection, though not everyone experiences it. Consult your doctor if you're concerned about hair loss.
Denoci-OP Injection isn't chemotherapy; it's a monoclonal antibody protein that combats bone loss and osteoporosis by targeting a specific protein. This treatment strengthens bones, reducing fracture risk.
Denoci-OP Injection is administered by a healthcare professional every six months. Your doctor might also recommend calcium and vitamin D supplements concurrently.
Pregnant women must not use Denoci-OP Injection. Effective contraception is required during and for five months after the final Denoci-OP Injection dose for women of childbearing potential.
Store Denoci-OP Injection in its original carton in a refrigerator at 2°C to 8°C (36°F to 46°F). Avoid warm temperatures to maintain effectiveness. Once removed, keep it at room temperature (up to 25°C/77°F) in the original carton and use within 14 days.
Jawbone damage (osteonecrosis) is a rare complication of Denoci-OP Injection. Maintain excellent oral hygiene and schedule regular dental checkups during treatment. Report any mouth or tooth problems—loose teeth, discharge, pain, swelling, or slow-healing sores—to your doctor and dentist immediately, as these may indicate osteonecrosis.
Denoci-OP Injection
12,960
MRP 15,000
13% off